

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptide cross-linking (GO:0018149) | 9.47436048 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.82842039 |
| 3 | regulation of keratinocyte differentiation (GO:0045616) | 7.76751102 |
| 4 | magnesium ion transport (GO:0015693) | 7.52800621 |
| 5 | cell-cell junction maintenance (GO:0045217) | 7.39988550 |
| 6 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 7.13052728 |
| 7 | response to vitamin A (GO:0033189) | 6.88005550 |
| 8 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 6.87422248 |
| 9 | ovulation from ovarian follicle (GO:0001542) | 6.78014661 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 6.57373010 |
| 11 | muscle organ morphogenesis (GO:0048644) | 6.12063985 |
| 12 | platelet dense granule organization (GO:0060155) | 5.99012308 |
| 13 | skeletal muscle contraction (GO:0003009) | 5.93505140 |
| 14 | cell junction maintenance (GO:0034331) | 5.91112717 |
| 15 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.90133261 |
| 16 | cytokine production involved in immune response (GO:0002367) | 5.86683220 |
| 17 | keratinocyte differentiation (GO:0030216) | 5.77184703 |
| 18 | purine nucleotide salvage (GO:0032261) | 5.67370882 |
| 19 | positive regulation of gastrulation (GO:2000543) | 5.62949106 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 5.58148667 |
| 21 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 5.55715265 |
| 22 | regulation of cardioblast proliferation (GO:0003264) | 5.55715265 |
| 23 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.34089933 |
| 24 | actin-myosin filament sliding (GO:0033275) | 5.33846999 |
| 25 | muscle filament sliding (GO:0030049) | 5.33846999 |
| 26 | regulation of skeletal muscle cell differentiation (GO:2001014) | 5.30142423 |
| 27 | embryonic heart tube development (GO:0035050) | 5.29473869 |
| 28 | innate immune response in mucosa (GO:0002227) | 5.20407698 |
| 29 | tooth mineralization (GO:0034505) | 5.07336945 |
| 30 | outer ear morphogenesis (GO:0042473) | 5.05531023 |
| 31 | coronary vasculature morphogenesis (GO:0060977) | 5.03892813 |
| 32 | regulation of regulatory T cell differentiation (GO:0045589) | 4.96126009 |
| 33 | positive regulation of vesicle fusion (GO:0031340) | 4.91095387 |
| 34 | lymph vessel development (GO:0001945) | 4.90734226 |
| 35 | linoleic acid metabolic process (GO:0043651) | 4.86966540 |
| 36 | regulation of gastrulation (GO:0010470) | 4.83632724 |
| 37 | arginine catabolic process (GO:0006527) | 4.80758252 |
| 38 | regulation of epidermal cell differentiation (GO:0045604) | 4.75813944 |
| 39 | cellular response to epidermal growth factor stimulus (GO:0071364) | 4.66665777 |
| 40 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 4.66047908 |
| 41 | cellular response to retinoic acid (GO:0071300) | 4.59666793 |
| 42 | mitochondrial calcium ion transport (GO:0006851) | 4.59112766 |
| 43 | establishment of endothelial barrier (GO:0061028) | 4.58004813 |
| 44 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 4.56901516 |
| 45 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.48294242 |
| 46 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 4.46777455 |
| 47 | actin-mediated cell contraction (GO:0070252) | 4.41362972 |
| 48 | glutathione biosynthetic process (GO:0006750) | 4.40707965 |
| 49 | organelle disassembly (GO:1903008) | 4.38868001 |
| 50 | T cell mediated immunity (GO:0002456) | 4.34002636 |
| 51 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 4.31570017 |
| 52 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.31331722 |
| 53 | nephron tubule formation (GO:0072079) | 4.29085305 |
| 54 | nitric oxide mediated signal transduction (GO:0007263) | 4.25116274 |
| 55 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 4.17910768 |
| 56 | Peyers patch development (GO:0048541) | 4.17361249 |
| 57 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.17361249 |
| 58 | peptide catabolic process (GO:0043171) | 4.16419124 |
| 59 | negative regulation of metanephros development (GO:0072217) | 4.15814727 |
| 60 | membrane raft organization (GO:0031579) | 4.13868262 |
| 61 | mucosal immune response (GO:0002385) | 4.12521195 |
| 62 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.10833758 |
| 63 | production of molecular mediator of immune response (GO:0002440) | 4.09596243 |
| 64 | ear development (GO:0043583) | 4.08539287 |
| 65 | ovulation (GO:0030728) | 4.07080765 |
| 66 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.05074581 |
| 67 | regulation of penile erection (GO:0060405) | 4.05028007 |
| 68 | regulation of protein kinase C signaling (GO:0090036) | 4.00840665 |
| 69 | muscle cell fate commitment (GO:0042693) | 3.99308189 |
| 70 | heart valve formation (GO:0003188) | 3.95288542 |
| 71 | epidermal cell differentiation (GO:0009913) | 3.94485315 |
| 72 | creatine metabolic process (GO:0006600) | 3.92020505 |
| 73 | organ or tissue specific immune response (GO:0002251) | 3.89899189 |
| 74 | histamine secretion (GO:0001821) | 3.89808776 |
| 75 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.88864957 |
| 76 | pattern specification involved in kidney development (GO:0061004) | 3.88673203 |
| 77 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.86825029 |
| 78 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.86825029 |
| 79 | mRNA transcription (GO:0009299) | 3.85484360 |
| 80 | mitotic G1/S transition checkpoint (GO:0044819) | 3.84131258 |
| 81 | positive regulation of protein depolymerization (GO:1901881) | 3.83860966 |
| 82 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.83365861 |
| 83 | cranial nerve morphogenesis (GO:0021602) | 3.82576814 |
| 84 | cellular component maintenance (GO:0043954) | 3.79679026 |
| 85 | response to epidermal growth factor (GO:0070849) | 3.79212087 |
| 86 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.78558991 |
| 87 | endoderm formation (GO:0001706) | 3.76560234 |
| 88 | cellular response to corticosteroid stimulus (GO:0071384) | 3.74542531 |
| 89 | hormone catabolic process (GO:0042447) | 3.74161031 |
| 90 | dorsal/ventral neural tube patterning (GO:0021904) | 3.72152680 |
| 91 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.67608075 |
| 92 | histamine transport (GO:0051608) | 3.62533691 |
| 93 | plasma membrane repair (GO:0001778) | 3.61305472 |
| 94 | negative regulation of cell fate specification (GO:0009996) | 3.58799655 |
| 95 | inositol phosphate-mediated signaling (GO:0048016) | 3.58217961 |
| 96 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.56367747 |
| 97 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55499291 |
| 98 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.54751306 |
| 99 | lipoxygenase pathway (GO:0019372) | 3.54747092 |
| 100 | tolerance induction (GO:0002507) | 3.53141234 |
| 101 | embryonic foregut morphogenesis (GO:0048617) | 3.52633105 |
| 102 | establishment of skin barrier (GO:0061436) | 3.51348013 |
| 103 | positive regulation of myotube differentiation (GO:0010831) | 3.50094969 |
| 104 | regulation of mesoderm development (GO:2000380) | 3.50064945 |
| 105 | endothelial cell development (GO:0001885) | 3.49960741 |
| 106 | microtubule depolymerization (GO:0007019) | 3.44170888 |
| 107 | diaphragm development (GO:0060539) | 3.43996157 |
| 108 | actin filament-based movement (GO:0030048) | 3.38721226 |
| 109 | cGMP-mediated signaling (GO:0019934) | 3.37143349 |
| 110 | striated muscle contraction (GO:0006941) | 3.36410545 |
| 111 | mature B cell differentiation involved in immune response (GO:0002313) | 3.35790266 |
| 112 | metanephric tubule development (GO:0072170) | 3.35638789 |
| 113 | metanephric nephron tubule development (GO:0072234) | 3.35638789 |
| 114 | myotube differentiation (GO:0014902) | 3.32230287 |
| 115 | arginine metabolic process (GO:0006525) | 3.27499485 |
| 116 | regulation of epidermis development (GO:0045682) | 3.25908026 |
| 117 | peptide biosynthetic process (GO:0043043) | 3.24812359 |
| 118 | regulation of transcription involved in cell fate commitment (GO:0060850) | 3.24675464 |
| 119 | regulation of germinal center formation (GO:0002634) | 3.24366863 |
| 120 | positive regulation of skeletal muscle tissue development (GO:0048643) | 3.24211528 |
| 121 | response to protozoan (GO:0001562) | 3.23716444 |
| 122 | heart trabecula formation (GO:0060347) | 3.23527690 |
| 123 | response to vitamin E (GO:0033197) | 3.23193244 |
| 124 | negative regulation of B cell apoptotic process (GO:0002903) | 3.23027535 |
| 125 | establishment of epithelial cell polarity (GO:0090162) | 3.21746200 |
| 126 | mannosylation (GO:0097502) | 3.21275157 |
| 127 | neural tube formation (GO:0001841) | 3.21077975 |
| 128 | mesonephros development (GO:0001823) | 3.20507679 |
| 129 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.19467052 |
| 130 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.19467052 |
| 131 | parturition (GO:0007567) | 3.17607962 |
| 132 | glycosphingolipid catabolic process (GO:0046479) | 3.17213691 |
| 133 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.16693702 |
| 134 | amyloid precursor protein catabolic process (GO:0042987) | 3.14933153 |
| 135 | regulation of water loss via skin (GO:0033561) | 3.14218047 |
| 136 | tricarboxylic acid cycle (GO:0006099) | 3.13624718 |
| 137 | lipoprotein metabolic process (GO:0042157) | 3.13306499 |
| 138 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 3.11905970 |
| 139 | exogenous drug catabolic process (GO:0042738) | 3.11081385 |
| 140 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.11058405 |
| 141 | nephron tubule development (GO:0072080) | 3.09605535 |
| 142 | desmosome organization (GO:0002934) | 3.09455871 |
| 143 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.09104925 |
| 144 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.08513376 |
| 145 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.08268261 |
| 146 | negative regulation of lipid storage (GO:0010888) | 3.03744444 |
| 147 | defense response to protozoan (GO:0042832) | 3.03082310 |
| 148 | myofibril assembly (GO:0030239) | 3.01384404 |
| 149 | keratinization (GO:0031424) | 20.3824741 |
| 150 | adenosine metabolic process (GO:0046085) | 2.99933674 |
| 151 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.96362745 |
| 152 | sarcomere organization (GO:0045214) | 2.96247720 |
| 153 | cytolysis (GO:0019835) | 2.95860002 |
| 154 | disruption of cells of other organism (GO:0044364) | 2.95546375 |
| 155 | killing of cells of other organism (GO:0031640) | 2.95546375 |
| 156 | skeletal muscle organ development (GO:0060538) | 2.95158893 |
| 157 | pharyngeal system development (GO:0060037) | 2.94861807 |
| 158 | negative regulation of fatty acid transport (GO:2000192) | 2.94815540 |
| 159 | metanephric nephron epithelium development (GO:0072243) | 2.94305070 |
| 160 | urogenital system development (GO:0001655) | 2.94044229 |
| 161 | regulation of stem cell maintenance (GO:2000036) | 2.91858820 |
| 162 | skeletal muscle fiber development (GO:0048741) | 2.91758178 |
| 163 | glomerular basement membrane development (GO:0032836) | 2.91465160 |
| 164 | negative regulation of T cell apoptotic process (GO:0070233) | 2.90138633 |
| 165 | response to muscle activity (GO:0014850) | 2.89903248 |
| 166 | synaptic vesicle endocytosis (GO:0048488) | 2.89184586 |
| 167 | embryonic epithelial tube formation (GO:0001838) | 2.87609605 |
| 168 | maintenance of protein location in nucleus (GO:0051457) | 2.86144683 |
| 169 | positive regulation of histone acetylation (GO:0035066) | 2.85840541 |
| 170 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.85740941 |
| 171 | glycolipid catabolic process (GO:0019377) | 2.84906756 |
| 172 | high-density lipoprotein particle remodeling (GO:0034375) | 2.83663773 |
| 173 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.81438390 |
| 174 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.81438390 |
| 175 | renal system development (GO:0072001) | 2.80915219 |
| 176 | cellular response to ATP (GO:0071318) | 2.80603791 |
| 177 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.75269828 |
| 178 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.75157152 |
| 179 | skeletal muscle adaptation (GO:0043501) | 2.73293481 |
| 180 | cochlea morphogenesis (GO:0090103) | 2.72474001 |
| 181 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.71449678 |
| 182 | outflow tract septum morphogenesis (GO:0003148) | 2.71411107 |
| 183 | positive regulation of protein complex disassembly (GO:0043243) | 2.71122017 |
| 184 | purine nucleobase biosynthetic process (GO:0009113) | 2.68421571 |
| 185 | otic vesicle formation (GO:0030916) | 2.67714868 |
| 186 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.64756348 |
| 187 | transcytosis (GO:0045056) | 2.61523798 |
| 188 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.60323311 |
| 189 | muscle contraction (GO:0006936) | 2.58624949 |
| 190 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.58087324 |
| 191 | positive regulation of heart rate (GO:0010460) | 2.57970986 |
| 192 | nucleotide salvage (GO:0043173) | 2.56563197 |
| 193 | negative regulation of digestive system process (GO:0060457) | 2.53026347 |
| 194 | negative regulation of circadian rhythm (GO:0042754) | 2.52633470 |
| 195 | cell wall macromolecule metabolic process (GO:0044036) | 14.2630676 |
| 196 | cell wall macromolecule catabolic process (GO:0016998) | 14.2630676 |
| 197 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 13.3767099 |
| 198 | iron coordination entity transport (GO:1901678) | 10.4987645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 9.92705021 |
| 2 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 8.13409455 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.97734002 |
| 4 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 6.37724706 |
| 5 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 4.23252132 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.64501817 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.25461941 |
| 8 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.99336781 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.98324191 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.98013575 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.82500496 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.79582140 |
| 13 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.58834165 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.37464667 |
| 15 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.24167666 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.16927757 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.16916294 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.10261379 |
| 19 | TP53_16413492_ChIP-PET_HCT116_Human | 2.02364751 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.00331599 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93624957 |
| 22 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.93248424 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88024421 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.81864022 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80128272 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74014665 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73372455 |
| 28 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.71288676 |
| 29 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.63159368 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62817275 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59970054 |
| 32 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58688179 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.55179879 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.53205277 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.52873232 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52232238 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50255131 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50183746 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.49802379 |
| 40 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.48276731 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47953971 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.47068190 |
| 43 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.46137961 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45644259 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.43034946 |
| 46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.42814809 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.40878095 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.38830535 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.38830535 |
| 50 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37437159 |
| 51 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.36703551 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35598772 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35585850 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35313536 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33695850 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33437773 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32992355 |
| 58 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.32449928 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31680229 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28498330 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27939707 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25775726 |
| 63 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.25328292 |
| 64 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.24454996 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24169456 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24044483 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23422141 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22364398 |
| 69 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.22151691 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21725656 |
| 71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21625739 |
| 72 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20373239 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20343590 |
| 74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.20044671 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.19436337 |
| 76 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.18456766 |
| 77 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18397576 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17739381 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17634695 |
| 80 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.15738059 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13849331 |
| 82 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.11501790 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10758463 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10639707 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10538515 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07142145 |
| 87 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.05704998 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05643961 |
| 89 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.05589843 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05327939 |
| 91 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.03483519 |
| 92 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.03479415 |
| 93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03403907 |
| 94 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02835349 |
| 95 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.02782736 |
| 96 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.02225718 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01510202 |
| 98 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01377669 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01357873 |
| 100 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.01336918 |
| 101 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01170024 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00546467 |
| 103 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00022589 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99756881 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99494078 |
| 106 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99146158 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98700227 |
| 108 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97777708 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97430572 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97306815 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97103631 |
| 112 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96708064 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96018247 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94599418 |
| 115 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94077895 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93462317 |
| 117 | P68_20966046_ChIP-Seq_HELA_Human | 0.93174711 |
| 118 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92708923 |
| 119 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92584036 |
| 120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92371163 |
| 121 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92266227 |
| 122 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.92160075 |
| 123 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92093643 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91372137 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90717250 |
| 126 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90005932 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89397846 |
| 128 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88755630 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88225451 |
| 130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87787802 |
| 131 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87717476 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87703587 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.87307575 |
| 134 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87218150 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87218150 |
| 136 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.87018998 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86950886 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85711997 |
| 139 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.85239911 |
| 140 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84175694 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84145991 |
| 142 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84047790 |
| 143 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84020186 |
| 144 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.84013788 |
| 145 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83497297 |
| 146 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83497297 |
| 147 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82683388 |
| 148 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82486102 |
| 149 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82109340 |
| 150 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82085496 |
| 151 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81854752 |
| 152 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81610437 |
| 153 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81452618 |
| 154 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79730955 |
| 155 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79508593 |
| 156 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79168991 |
| 157 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.79143342 |
| 158 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.79011116 |
| 159 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.79003817 |
| 160 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78650119 |
| 161 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.78604338 |
| 162 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78429402 |
| 163 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.78219111 |
| 164 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78053578 |
| 165 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77683699 |
| 166 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.77583461 |
| 167 | ERA_21632823_ChIP-Seq_H3396_Human | 0.77559633 |
| 168 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77278552 |
| 169 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.76740633 |
| 170 | SA1_27219007_Chip-Seq_Bcells_Human | 0.75130721 |
| 171 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74271382 |
| 172 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74124514 |
| 173 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.72610997 |
| 174 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.72387653 |
| 175 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.70701488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002234_abnormal_pharynx_morphology | 5.59724808 |
| 2 | MP0000751_myopathy | 5.19691114 |
| 3 | MP0002796_impaired_skin_barrier | 4.98679700 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 4.82901556 |
| 5 | MP0003646_muscle_fatigue | 4.73985824 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 4.58575557 |
| 7 | MP0005275_abnormal_skin_tensile | 4.17865348 |
| 8 | MP0000749_muscle_degeneration | 3.95068054 |
| 9 | MP0005083_abnormal_biliary_tract | 3.80538818 |
| 10 | MP0000467_abnormal_esophagus_morphology | 3.72041954 |
| 11 | MP0001501_abnormal_sleep_pattern | 3.67680608 |
| 12 | MP0000762_abnormal_tongue_morphology | 3.39851505 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.36548572 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 3.33933072 |
| 15 | MP0009840_abnormal_foam_cell | 3.17595646 |
| 16 | MP0004145_abnormal_muscle_electrophysio | 2.93852851 |
| 17 | MP0003828_pulmonary_edema | 2.93693705 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.85101666 |
| 19 | MP0009697_abnormal_copulation | 2.77308016 |
| 20 | MP0000747_muscle_weakness | 2.75354080 |
| 21 | MP0005501_abnormal_skin_physiology | 2.74335682 |
| 22 | MP0000759_abnormal_skeletal_muscle | 2.55511474 |
| 23 | MP0005503_abnormal_tendon_morphology | 2.55407448 |
| 24 | MP0001873_stomach_inflammation | 2.51780776 |
| 25 | MP0002106_abnormal_muscle_physiology | 2.48856198 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.32212026 |
| 27 | MP0002095_abnormal_skin_pigmentation | 2.26455581 |
| 28 | MP0005084_abnormal_gallbladder_morpholo | 2.23825768 |
| 29 | MP0004130_abnormal_muscle_cell | 2.22801825 |
| 30 | MP0000678_abnormal_parathyroid_gland | 2.22549582 |
| 31 | MP0001243_abnormal_dermal_layer | 2.14836421 |
| 32 | MP0004087_abnormal_muscle_fiber | 2.06957468 |
| 33 | MP0002160_abnormal_reproductive_system | 2.01839526 |
| 34 | MP0005257_abnormal_intraocular_pressure | 2.01720255 |
| 35 | MP0005369_muscle_phenotype | 2.01501094 |
| 36 | MP0003252_abnormal_bile_duct | 2.01111888 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 2.00791905 |
| 38 | MP0000750_abnormal_muscle_regeneration | 1.99198566 |
| 39 | MP0004270_analgesia | 1.90671472 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.87037868 |
| 41 | MP0000371_diluted_coat_color | 1.85717016 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.82216985 |
| 43 | MP0003879_abnormal_hair_cell | 1.81496742 |
| 44 | MP0000733_abnormal_muscle_development | 1.78961346 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.72215257 |
| 46 | MP0005389_reproductive_system_phenotype | 1.70291066 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.68242412 |
| 48 | MP0002269_muscular_atrophy | 1.66353256 |
| 49 | MP0002249_abnormal_larynx_morphology | 1.66202578 |
| 50 | MP0001919_abnormal_reproductive_system | 1.59800658 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.53855826 |
| 52 | MP0000685_abnormal_immune_system | 1.51319027 |
| 53 | MP0005197_abnormal_uvea_morphology | 1.48875139 |
| 54 | MP0000470_abnormal_stomach_morphology | 1.47905506 |
| 55 | MP0001879_abnormal_lymphatic_vessel | 1.47113861 |
| 56 | MP0001756_abnormal_urination | 1.44271009 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.40289708 |
| 58 | MP0003943_abnormal_hepatobiliary_system | 1.35011752 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.34494270 |
| 60 | MP0002136_abnormal_kidney_physiology | 1.32942173 |
| 61 | MP0005330_cardiomyopathy | 1.31323135 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.30984365 |
| 63 | MP0006292_abnormal_olfactory_placode | 1.29192687 |
| 64 | MP0003436_decreased_susceptibility_to | 1.29116917 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.27468222 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.27168340 |
| 67 | MP0005266_abnormal_metabolism | 1.25651915 |
| 68 | MP0002127_abnormal_cardiovascular_syste | 1.24906992 |
| 69 | MP0000534_abnormal_ureter_morphology | 1.24893159 |
| 70 | MP0003045_fibrosis | 1.20681115 |
| 71 | MP0002972_abnormal_cardiac_muscle | 1.18621115 |
| 72 | MP0000639_abnormal_adrenal_gland | 1.18484825 |
| 73 | MP0000579_abnormal_nail_morphology | 1.14773954 |
| 74 | MP0003938_abnormal_ear_development | 1.13409133 |
| 75 | MP0002928_abnormal_bile_duct | 1.13129160 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.12702003 |
| 77 | MP0001765_abnormal_ion_homeostasis | 1.10612209 |
| 78 | MP0010771_integument_phenotype | 1.10552608 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.09531723 |
| 80 | MP0008872_abnormal_physiological_respon | 1.08702263 |
| 81 | MP0009785_altered_susceptibility_to | 1.05095032 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.04995376 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.04820657 |
| 84 | MP0001881_abnormal_mammary_gland | 1.03575869 |
| 85 | MP0010329_abnormal_lipoprotein_level | 1.02523051 |
| 86 | MP0001216_abnormal_epidermal_layer | 1.02473116 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 1.00912249 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00014997 |
| 89 | MP0002184_abnormal_innervation | 0.99369022 |
| 90 | MP0005332_abnormal_amino_acid | 0.97542966 |
| 91 | MP0004233_abnormal_muscle_weight | 0.97073254 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.96828400 |
| 93 | MP0002254_reproductive_system_inflammat | 0.96434970 |
| 94 | MP0004084_abnormal_cardiac_muscle | 0.95067681 |
| 95 | MP0000647_abnormal_sebaceous_gland | 0.94812915 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.93606745 |
| 97 | MP0002075_abnormal_coat/hair_pigmentati | 0.93495425 |
| 98 | MP0000049_abnormal_middle_ear | 0.92641045 |
| 99 | MP0005375_adipose_tissue_phenotype | 0.90741412 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89486719 |
| 101 | MP0001663_abnormal_digestive_system | 0.89478418 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.89342575 |
| 103 | MP0001851_eye_inflammation | 0.89215434 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.89162689 |
| 105 | MP0006054_spinal_hemorrhage | 0.88792909 |
| 106 | MP0004484_altered_response_of | 0.88689861 |
| 107 | MP0005365_abnormal_bile_salt | 0.87486294 |
| 108 | MP0004947_skin_inflammation | 0.86937217 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.84972504 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.84453460 |
| 111 | MP0005390_skeleton_phenotype | 0.82830188 |
| 112 | MP0003866_abnormal_defecation | 0.82778760 |
| 113 | MP0005025_abnormal_response_to | 0.81616517 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.81344087 |
| 115 | MP0005451_abnormal_body_composition | 0.81120947 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.80929727 |
| 117 | MP0002405_respiratory_system_inflammati | 0.78470719 |
| 118 | MP0000613_abnormal_salivary_gland | 0.78212433 |
| 119 | MP0000427_abnormal_hair_cycle | 0.75030452 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.74520668 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.74187166 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.73799710 |
| 123 | MP0008961_abnormal_basal_metabolism | 0.71766720 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.71698624 |
| 125 | MP0002971_abnormal_brown_adipose | 0.71618181 |
| 126 | MP0003936_abnormal_reproductive_system | 0.71016235 |
| 127 | MP0004859_abnormal_synaptic_plasticity | 0.70848373 |
| 128 | MP0009763_increased_sensitivity_to | 0.70786092 |
| 129 | MP0004272_abnormal_basement_membrane | 0.70056623 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.69934898 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.68320016 |
| 132 | MP0005385_cardiovascular_system_phenoty | 0.68320016 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.68270281 |
| 134 | MP0002139_abnormal_hepatobiliary_system | 0.67239972 |
| 135 | MP0001191_abnormal_skin_condition | 0.66425490 |
| 136 | MP0010630_abnormal_cardiac_muscle | 0.65861701 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.65337712 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.63581855 |
| 139 | MP0001186_pigmentation_phenotype | 0.63147601 |
| 140 | MP0000367_abnormal_coat/_hair | 0.62226554 |
| 141 | MP0008569_lethality_at_weaning | 0.62058635 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.61152649 |
| 143 | MP0001800_abnormal_humoral_immune | 0.61087805 |
| 144 | MP0004043_abnormal_pH_regulation | 0.60716548 |
| 145 | MP0009931_abnormal_skin_appearance | 0.59996898 |
| 146 | MP0003329_amyloid_beta_deposits | 0.59781610 |
| 147 | MP0003699_abnormal_female_reproductive | 0.59465228 |
| 148 | MP0001177_atelectasis | 0.58776512 |
| 149 | MP0005508_abnormal_skeleton_morphology | 0.58667729 |
| 150 | MP0003755_abnormal_palate_morphology | 0.58322177 |
| 151 | MP0005410_abnormal_fertilization | 0.58092163 |
| 152 | MP0000566_synostosis | 0.57686276 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.55540720 |
| 154 | MP0005334_abnormal_fat_pad | 0.53384085 |
| 155 | MP0005085_abnormal_gallbladder_physiolo | 0.51449099 |
| 156 | MP0006138_congestive_heart_failure | 0.51425601 |
| 157 | MP0003950_abnormal_plasma_membrane | 0.51365420 |
| 158 | MP0003635_abnormal_synaptic_transmissio | 0.51112586 |
| 159 | MP0010030_abnormal_orbit_morphology | 0.50903429 |
| 160 | MP0000465_gastrointestinal_hemorrhage | 0.49383993 |
| 161 | MP0004858_abnormal_nervous_system | 0.49026820 |
| 162 | MP0001346_abnormal_lacrimal_gland | 0.48134342 |
| 163 | MP0000013_abnormal_adipose_tissue | 0.47943740 |
| 164 | MP0002177_abnormal_outer_ear | 0.47707309 |
| 165 | MP0001943_abnormal_respiration | 0.46240662 |
| 166 | MP0002060_abnormal_skin_morphology | 0.45501031 |
| 167 | MP0010678_abnormal_skin_adnexa | 0.44942902 |
| 168 | MP0005535_abnormal_body_temperature | 0.43966387 |
| 169 | MP0008775_abnormal_heart_ventricle | 0.42712891 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.41800816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypomagnesemia (HP:0002917) | 8.82322084 |
| 2 | Abnormality of magnesium homeostasis (HP:0004921) | 7.42995138 |
| 3 | Abnormal drinking behavior (HP:0030082) | 7.37413395 |
| 4 | Polydipsia (HP:0001959) | 7.37413395 |
| 5 | Distal arthrogryposis (HP:0005684) | 6.59386290 |
| 6 | Muscle fiber inclusion bodies (HP:0100299) | 6.54500775 |
| 7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.53762666 |
| 8 | Exercise-induced myalgia (HP:0003738) | 6.36831672 |
| 9 | Nemaline bodies (HP:0003798) | 5.92599832 |
| 10 | Round ear (HP:0100830) | 5.44738516 |
| 11 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.18961809 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 5.12837796 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 5.07191508 |
| 14 | Absent phalangeal crease (HP:0006109) | 4.88266879 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.88032650 |
| 16 | Increased connective tissue (HP:0009025) | 4.81960397 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 4.80961363 |
| 18 | Polyuria (HP:0000103) | 4.80691622 |
| 19 | Hyperuricemia (HP:0002149) | 4.73391215 |
| 20 | Increased purine levels (HP:0004368) | 4.73391215 |
| 21 | Difficulty running (HP:0009046) | 4.66882348 |
| 22 | Myopathic facies (HP:0002058) | 4.66642899 |
| 23 | Calcaneovalgus deformity (HP:0001848) | 4.49094557 |
| 24 | Abnormality of the vertebral endplates (HP:0005106) | 4.45690045 |
| 25 | Flattened epiphyses (HP:0003071) | 4.38999354 |
| 26 | Renal tubular acidosis (HP:0001947) | 4.36748567 |
| 27 | Myoglobinuria (HP:0002913) | 4.30420335 |
| 28 | Rimmed vacuoles (HP:0003805) | 4.28409242 |
| 29 | Deformed tarsal bones (HP:0008119) | 4.19315193 |
| 30 | Enlarged epiphyses (HP:0010580) | 4.14132778 |
| 31 | Spinal muscular atrophy (HP:0007269) | 4.12958564 |
| 32 | Muscle fiber splitting (HP:0003555) | 4.11390947 |
| 33 | Abnormal finger flexion creases (HP:0006143) | 4.05147164 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 4.04530852 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.04530852 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.04530852 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 4.00918659 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 3.97393526 |
| 39 | Abnormal urine output (HP:0012590) | 3.96070757 |
| 40 | Increased IgE level (HP:0003212) | 3.94028158 |
| 41 | Stomach cancer (HP:0012126) | 3.90653766 |
| 42 | Polygenic inheritance (HP:0010982) | 3.89361805 |
| 43 | Stridor (HP:0010307) | 3.87654277 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 3.87627440 |
| 45 | Unilateral renal agenesis (HP:0000122) | 3.86446625 |
| 46 | Hypothermia (HP:0002045) | 3.84872940 |
| 47 | Thyroid-stimulating hormone excess (HP:0002925) | 3.84439754 |
| 48 | Abnormality of the anterior horn cell (HP:0006802) | 3.81351017 |
| 49 | Degeneration of anterior horn cells (HP:0002398) | 3.81351017 |
| 50 | Split foot (HP:0001839) | 3.66723130 |
| 51 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.62619243 |
| 52 | Congenital malformation of the right heart (HP:0011723) | 3.55621145 |
| 53 | Double outlet right ventricle (HP:0001719) | 3.55621145 |
| 54 | Diaphragmatic weakness (HP:0009113) | 3.45711353 |
| 55 | Hypercalciuria (HP:0002150) | 3.40895878 |
| 56 | Mesangial abnormality (HP:0001966) | 3.37956521 |
| 57 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.37351893 |
| 58 | Abnormality of renal excretion (HP:0011036) | 3.30436430 |
| 59 | Abnormality of the calf musculature (HP:0001430) | 3.29392875 |
| 60 | Autoimmune hemolytic anemia (HP:0001890) | 3.26121627 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 3.24083873 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 3.24049546 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 3.16203814 |
| 64 | Focal segmental glomerulosclerosis (HP:0000097) | 3.15609428 |
| 65 | Abnormality of the parathyroid morphology (HP:0011766) | 3.15199763 |
| 66 | EMG: myopathic abnormalities (HP:0003458) | 3.11348527 |
| 67 | Myotonia (HP:0002486) | 3.08749023 |
| 68 | Abnormality of the aortic arch (HP:0012303) | 3.07815224 |
| 69 | Distal lower limb amyotrophy (HP:0008944) | 3.02960300 |
| 70 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.00243165 |
| 71 | Cholelithiasis (HP:0001081) | 3.00147525 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.97594035 |
| 73 | Muscle stiffness (HP:0003552) | 2.96928323 |
| 74 | Paralysis (HP:0003470) | 2.93995928 |
| 75 | Hyperthyroidism (HP:0000836) | 2.93565026 |
| 76 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.84768304 |
| 77 | Weak cry (HP:0001612) | 2.84301749 |
| 78 | Areflexia of lower limbs (HP:0002522) | 2.82106927 |
| 79 | Dysautonomia (HP:0002459) | 2.80195031 |
| 80 | Neck muscle weakness (HP:0000467) | 2.75632714 |
| 81 | Renal tubular dysfunction (HP:0000124) | 2.75608104 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.73766874 |
| 83 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.72521485 |
| 84 | Synostosis involving the elbow (HP:0003938) | 2.72026095 |
| 85 | Humeroradial synostosis (HP:0003041) | 2.72026095 |
| 86 | Cupped ribs (HP:0000887) | 2.71985966 |
| 87 | Nephrocalcinosis (HP:0000121) | 2.66488956 |
| 88 | Difficulty climbing stairs (HP:0003551) | 2.66006675 |
| 89 | B lymphocytopenia (HP:0010976) | 2.64081623 |
| 90 | Abnormality of B cell number (HP:0010975) | 2.64081623 |
| 91 | Abnormality of the calcaneus (HP:0008364) | 2.63267633 |
| 92 | Rhabdomyolysis (HP:0003201) | 2.61744265 |
| 93 | Coxa vara (HP:0002812) | 2.61493617 |
| 94 | Large for gestational age (HP:0001520) | 2.61112334 |
| 95 | Barrel-shaped chest (HP:0001552) | 2.61022155 |
| 96 | Bicornuate uterus (HP:0000813) | 2.54075387 |
| 97 | Facial diplegia (HP:0001349) | 2.52299384 |
| 98 | Abnormality of femoral epiphyses (HP:0006499) | 2.49721728 |
| 99 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.49721728 |
| 100 | Hypoplastic ischia (HP:0003175) | 2.48307279 |
| 101 | Glomerulosclerosis (HP:0000096) | 2.45060225 |
| 102 | Abnormality of the femoral head (HP:0003368) | 2.42774764 |
| 103 | Frequent falls (HP:0002359) | 2.40813331 |
| 104 | Absent epiphyses (HP:0010577) | 2.37982306 |
| 105 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.37982306 |
| 106 | Lower limb amyotrophy (HP:0007210) | 2.36027196 |
| 107 | Hypoplastic iliac wings (HP:0002866) | 2.34919907 |
| 108 | Hypoplastic left heart (HP:0004383) | 2.31875095 |
| 109 | Tetany (HP:0001281) | 2.27797561 |
| 110 | Recurrent abscess formation (HP:0002722) | 2.25007187 |
| 111 | Short palpebral fissure (HP:0012745) | 2.20816346 |
| 112 | Hyperkalemia (HP:0002153) | 2.20690026 |
| 113 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.19245028 |
| 114 | Abnormality of the ischium (HP:0003174) | 2.18022813 |
| 115 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.16900541 |
| 116 | Nasal speech (HP:0001611) | 2.16278783 |
| 117 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.15878955 |
| 118 | Amblyopia (HP:0000646) | 2.15810154 |
| 119 | Tachypnea (HP:0002789) | 2.15440936 |
| 120 | Hypoplasia of the radius (HP:0002984) | 2.15408628 |
| 121 | Conical tooth (HP:0000698) | 2.15144611 |
| 122 | Shoulder girdle muscle weakness (HP:0003547) | 2.12233244 |
| 123 | Septate vagina (HP:0001153) | 2.08679990 |
| 124 | Ileus (HP:0002595) | 2.07184847 |
| 125 | Akinesia (HP:0002304) | 2.05964323 |
| 126 | Ulnar deviation of finger (HP:0009465) | 2.05207783 |
| 127 | Nonimmune hydrops fetalis (HP:0001790) | 2.05012933 |
| 128 | Hydroureter (HP:0000072) | 2.03827769 |
| 129 | Scapular winging (HP:0003691) | 2.03693619 |
| 130 | Eczematoid dermatitis (HP:0000976) | 2.03656889 |
| 131 | Exotropia (HP:0000577) | 2.03052940 |
| 132 | Multifactorial inheritance (HP:0001426) | 2.02809605 |
| 133 | Hypokinesia (HP:0002375) | 2.02289796 |
| 134 | Aplasia involving bones of the extremities (HP:0009825) | 2.00870090 |
| 135 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00870090 |
| 136 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00870090 |
| 137 | Oral leukoplakia (HP:0002745) | 11.4680063 |
| 138 | Abnormality of nucleobase metabolism (HP:0010932) | 1.99173721 |
| 139 | Delusions (HP:0000746) | 1.99129632 |
| 140 | Thyroiditis (HP:0100646) | 1.98644038 |
| 141 | Pelvic girdle muscle weakness (HP:0003749) | 1.97878085 |
| 142 | Oligodactyly (hands) (HP:0001180) | 1.97144302 |
| 143 | Wrist flexion contracture (HP:0001239) | 1.96731446 |
| 144 | Seborrheic dermatitis (HP:0001051) | 1.96542380 |
| 145 | Adactyly (HP:0009776) | 1.96510243 |
| 146 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.96263381 |
| 147 | Opisthotonus (HP:0002179) | 1.96146431 |
| 148 | Albinism (HP:0001022) | 1.92839072 |
| 149 | Hematuria (HP:0000790) | 1.92704293 |
| 150 | Muscular dystrophy (HP:0003560) | 1.92615099 |
| 151 | Methylmalonic aciduria (HP:0012120) | 1.88488573 |
| 152 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.88386165 |
| 153 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.88386165 |
| 154 | Mitral stenosis (HP:0001718) | 1.87985434 |
| 155 | Osteoarthritis (HP:0002758) | 1.87850218 |
| 156 | Foot dorsiflexor weakness (HP:0009027) | 1.87843068 |
| 157 | Hypertensive crisis (HP:0100735) | 1.86907331 |
| 158 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.86180457 |
| 159 | Severe combined immunodeficiency (HP:0004430) | 1.85494845 |
| 160 | Ectropion (HP:0000656) | 1.82383164 |
| 161 | Abdominal distention (HP:0003270) | 1.80490203 |
| 162 | Corneal erosion (HP:0200020) | 1.78847494 |
| 163 | Annular pancreas (HP:0001734) | 1.78279534 |
| 164 | Achilles tendon contracture (HP:0001771) | 1.76712245 |
| 165 | Poor speech (HP:0002465) | 1.76380528 |
| 166 | Irregular vertebral endplates (HP:0003301) | 1.75078149 |
| 167 | Neonatal hypoglycemia (HP:0001998) | 1.73972936 |
| 168 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.73875784 |
| 169 | Abnormality of the gallbladder (HP:0005264) | 1.73735501 |
| 170 | Absence seizures (HP:0002121) | 1.73306040 |
| 171 | Joint swelling (HP:0001386) | 1.73194730 |
| 172 | Rectal fistula (HP:0100590) | 1.72473157 |
| 173 | Rectovaginal fistula (HP:0000143) | 1.72473157 |
| 174 | Woolly hair (HP:0002224) | 1.72233459 |
| 175 | Mesomelia (HP:0003027) | 1.72125374 |
| 176 | EMG: neuropathic changes (HP:0003445) | 1.71986033 |
| 177 | Anal stenosis (HP:0002025) | 1.71798127 |
| 178 | Hypoplastic pelvis (HP:0008839) | 1.71244424 |
| 179 | Supranuclear gaze palsy (HP:0000605) | 1.70780392 |
| 180 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.70480486 |
| 181 | Irregular epiphyses (HP:0010582) | 1.70448891 |
| 182 | Abnormality of the foot musculature (HP:0001436) | 1.70124894 |
| 183 | Abnormality of the Achilles tendon (HP:0005109) | 1.69145641 |
| 184 | Long clavicles (HP:0000890) | 1.68278736 |
| 185 | Spinal rigidity (HP:0003306) | 1.67672190 |
| 186 | Chronic diarrhea (HP:0002028) | 1.65677953 |
| 187 | Absent hand (HP:0004050) | 1.65651048 |
| 188 | Hypoplastic heart (HP:0001961) | 1.65346651 |
| 189 | Gout (HP:0001997) | 1.64633589 |
| 190 | Metatarsus adductus (HP:0001840) | 1.64466270 |
| 191 | Proximal amyotrophy (HP:0007126) | 1.62531710 |
| 192 | Palmoplantar keratoderma (HP:0000982) | 1.62349067 |
| 193 | Intestinal fistula (HP:0100819) | 1.61501869 |
| 194 | Fibular aplasia (HP:0002990) | 1.61212960 |
| 195 | Stage 5 chronic kidney disease (HP:0003774) | 1.60846855 |
| 196 | Truncus arteriosus (HP:0001660) | 1.59810829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 4.91373786 |
| 2 | MAPK15 | 4.82954851 |
| 3 | TAOK3 | 4.72221421 |
| 4 | OBSCN | 3.85746353 |
| 5 | TLK1 | 3.31145150 |
| 6 | PHKG2 | 3.30092616 |
| 7 | PHKG1 | 3.30092616 |
| 8 | CSF1R | 2.79762273 |
| 9 | NEK1 | 2.65165167 |
| 10 | PDK3 | 2.33260785 |
| 11 | PDK4 | 2.33260785 |
| 12 | TRIB3 | 2.29497886 |
| 13 | MAP2K3 | 2.11707559 |
| 14 | MAP3K14 | 2.06193137 |
| 15 | IKBKE | 2.05115274 |
| 16 | TTN | 10.7816907 |
| 17 | BCKDK | 1.91242960 |
| 18 | PINK1 | 1.83872099 |
| 19 | AKT3 | 1.83328098 |
| 20 | TYK2 | 1.80339981 |
| 21 | NME1 | 1.78297050 |
| 22 | NEK2 | 1.75100036 |
| 23 | DMPK | 1.62870809 |
| 24 | PDK2 | 1.54744289 |
| 25 | MKNK2 | 1.42469097 |
| 26 | EPHA3 | 1.39242065 |
| 27 | MAP2K4 | 1.31683872 |
| 28 | MAP3K7 | 1.31346442 |
| 29 | JAK1 | 1.29557593 |
| 30 | TBK1 | 1.25144277 |
| 31 | EPHA2 | 1.23619594 |
| 32 | CAMK1 | 1.17204188 |
| 33 | TAOK1 | 1.16451206 |
| 34 | CDK7 | 1.12643114 |
| 35 | ADRBK2 | 1.11770281 |
| 36 | MAP3K3 | 1.10617427 |
| 37 | SIK1 | 1.10507045 |
| 38 | ILK | 1.08346741 |
| 39 | MAPK12 | 1.07954029 |
| 40 | MAP2K2 | 1.05263980 |
| 41 | MAPKAPK3 | 1.04018412 |
| 42 | PRKCI | 1.02216265 |
| 43 | PKN2 | 0.99440631 |
| 44 | FER | 0.95349808 |
| 45 | MARK3 | 0.90707122 |
| 46 | FGFR2 | 0.90536702 |
| 47 | PAK6 | 0.88867197 |
| 48 | EIF2AK2 | 0.88782710 |
| 49 | MAP3K9 | 0.88011788 |
| 50 | KSR2 | 0.87490889 |
| 51 | CSNK1A1 | 0.87449305 |
| 52 | UHMK1 | 0.86703625 |
| 53 | SIK2 | 0.82486285 |
| 54 | STK4 | 0.82467332 |
| 55 | CAMK2A | 0.80453573 |
| 56 | OXSR1 | 0.78809102 |
| 57 | PRKD2 | 0.78380039 |
| 58 | SYK | 0.77886218 |
| 59 | NTRK2 | 0.75840872 |
| 60 | IRAK4 | 0.75278739 |
| 61 | MARK1 | 0.75274785 |
| 62 | PIK3CA | 0.73875215 |
| 63 | IGF1R | 0.70898010 |
| 64 | MAP2K6 | 0.69521128 |
| 65 | RIPK1 | 0.68507784 |
| 66 | ACVR1B | 0.66250753 |
| 67 | WNK4 | 0.65949818 |
| 68 | EPHB1 | 0.65852578 |
| 69 | PIM1 | 0.64292027 |
| 70 | CLK1 | 0.62884312 |
| 71 | PRKD1 | 0.62343220 |
| 72 | MAP4K2 | 0.59459023 |
| 73 | BTK | 0.58666786 |
| 74 | LIMK1 | 0.58055655 |
| 75 | KSR1 | 0.56562295 |
| 76 | ERBB2 | 0.53565345 |
| 77 | NTRK3 | 0.51969416 |
| 78 | JAK2 | 0.51197692 |
| 79 | PTK6 | 0.51149206 |
| 80 | ERBB3 | 0.50820067 |
| 81 | HCK | 0.50225846 |
| 82 | PKN1 | 0.49504753 |
| 83 | CAMKK2 | 0.48954028 |
| 84 | DYRK1B | 0.48772714 |
| 85 | LRRK2 | 0.48417940 |
| 86 | MKNK1 | 0.48302184 |
| 87 | IKBKB | 0.46786985 |
| 88 | KIT | 0.45680640 |
| 89 | MAPK11 | 0.44969037 |
| 90 | HIPK2 | 0.44880630 |
| 91 | MAP2K1 | 0.44775594 |
| 92 | MAP3K2 | 0.44773486 |
| 93 | BMX | 0.44443949 |
| 94 | RPS6KB2 | 0.44142144 |
| 95 | CAMK2G | 0.43918946 |
| 96 | LATS2 | 0.43591623 |
| 97 | CHUK | 0.42954858 |
| 98 | ERN1 | 0.42383795 |
| 99 | MAP3K11 | 0.42236983 |
| 100 | RPS6KA6 | 0.40471679 |
| 101 | MAP3K6 | 0.39114688 |
| 102 | FGR | 0.38345401 |
| 103 | PRKCQ | 0.38344610 |
| 104 | VRK1 | 0.37532038 |
| 105 | SGK1 | 0.37221105 |
| 106 | WNK1 | 0.37014253 |
| 107 | STK39 | 0.36857482 |
| 108 | MAPK4 | 0.36707474 |
| 109 | NME2 | 0.36682761 |
| 110 | MAP3K1 | 0.34212443 |
| 111 | PTK2B | 0.32961003 |
| 112 | PAK3 | 0.32585927 |
| 113 | MST1R | 0.32519957 |
| 114 | DDR2 | 0.31829289 |
| 115 | INSR | 0.31552286 |
| 116 | ROCK2 | 0.31347143 |
| 117 | RPS6KC1 | 0.31255916 |
| 118 | RPS6KL1 | 0.31255916 |
| 119 | FES | 0.31194541 |
| 120 | BRSK2 | 0.31191440 |
| 121 | TAOK2 | 0.31060217 |
| 122 | CDK11A | 0.30929310 |
| 123 | CSNK1D | 0.30739163 |
| 124 | PRKCH | 0.30488163 |
| 125 | TYRO3 | 0.30401625 |
| 126 | RET | 0.29941498 |
| 127 | EPHA4 | 0.29453107 |
| 128 | PRKCG | 0.29358076 |
| 129 | PDPK1 | 0.29121029 |
| 130 | PRKACA | 0.28930628 |
| 131 | PRKG1 | 0.28799465 |
| 132 | AKT2 | 0.28093139 |
| 133 | PAK2 | 0.27995568 |
| 134 | CDK5 | 0.27917944 |
| 135 | ROCK1 | 0.26987269 |
| 136 | TNIK | 0.26406040 |
| 137 | PTK2 | 0.25884419 |
| 138 | GRK1 | 0.25748209 |
| 139 | LCK | 0.25571977 |
| 140 | EGFR | 0.25508775 |
| 141 | RPS6KA3 | 0.25326490 |
| 142 | GSK3A | 0.25168965 |
| 143 | CAMK4 | 0.24963664 |
| 144 | LATS1 | 0.24734042 |
| 145 | LYN | 0.24315219 |
| 146 | PRKAA2 | 0.24257079 |
| 147 | PDK1 | 0.23733335 |
| 148 | MTOR | 0.23698905 |
| 149 | FGFR4 | 0.23481241 |
| 150 | CAMKK1 | 0.23263992 |
| 151 | MET | 0.23231630 |
| 152 | MAPK3 | 0.23198646 |
| 153 | GRK6 | 0.23040867 |
| 154 | INSRR | 0.22545749 |
| 155 | MAPKAPK2 | 0.22377294 |
| 156 | MAPK13 | 0.21642828 |
| 157 | PRKACG | 0.21153495 |
| 158 | MARK2 | 0.21146465 |
| 159 | TIE1 | 0.20868865 |
| 160 | PDGFRA | 0.20565747 |
| 161 | CASK | 0.20461453 |
| 162 | NTRK1 | 0.20430501 |
| 163 | CAMK2B | 0.20094755 |
| 164 | PRKACB | 0.19604384 |
| 165 | CDK19 | 0.19323038 |
| 166 | MAPK9 | 0.17183433 |
| 167 | DYRK2 | 0.16890716 |
| 168 | SIK3 | 0.16446549 |
| 169 | FGFR1 | 0.15943251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.09512593 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.05598277 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 4.01857202 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.76991937 |
| 5 | African trypanosomiasis_Homo sapiens_hsa05143 | 3.62045754 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.32688519 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 3.13192610 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.07169016 |
| 9 | * Salivary secretion_Homo sapiens_hsa04970 | 2.91554727 |
| 10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.57667644 |
| 11 | Hepatitis C_Homo sapiens_hsa05160 | 2.40075047 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.25790440 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.20664275 |
| 14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.13087826 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.13053818 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.08919469 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 2.07668144 |
| 18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.91476431 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88277907 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88210907 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.83473587 |
| 22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.78378336 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76506848 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.75837273 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.71714833 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.68258316 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.65334092 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63381215 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.60327114 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60256607 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.55243677 |
| 32 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.52365724 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47644073 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46467768 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45987106 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44097382 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.38101439 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37355085 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.37214767 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.33785979 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31804245 |
| 42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.31604701 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.28954571 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27285448 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.27252446 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24124562 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.23135621 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22223962 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.20994550 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20230311 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.17346593 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16952092 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.16669933 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16489810 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16358459 |
| 56 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.15722389 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14141100 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12545882 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.12287256 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08990767 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07269985 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 1.03877354 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03033637 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02551061 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.01009251 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00811555 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00478810 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99458958 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97556211 |
| 70 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96350483 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96285810 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96230694 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95580026 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94037032 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93799284 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92774880 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90681808 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87859423 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84161334 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.84079621 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83015989 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82070999 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.82045517 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.81361447 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78390470 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77697263 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77624668 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77220238 |
| 89 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.76986192 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75973064 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73864137 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71784080 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70682530 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70408529 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70382857 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.70147014 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70066456 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67607807 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67507918 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66069890 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65791346 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65660339 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64843978 |
| 104 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.64492785 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.63841702 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.62867118 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62038881 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61631926 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61257345 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61053151 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.59882180 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58669791 |
| 113 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57012651 |
| 114 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56843849 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.56273015 |
| 116 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55744647 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55186969 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54152181 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53920736 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52270720 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51219357 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.50022535 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.48345624 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47563047 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46036855 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46027184 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.44956315 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44200479 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44174515 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41617990 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.39768199 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39290875 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38758957 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38303111 |
| 135 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37613993 |
| 136 | Purine metabolism_Homo sapiens_hsa00230 | 0.37302698 |
| 137 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37042680 |
| 138 | Insulin secretion_Homo sapiens_hsa04911 | 0.36930711 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35159579 |
| 140 | Bile secretion_Homo sapiens_hsa04976 | 0.35158005 |
| 141 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34901917 |
| 142 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33644685 |
| 143 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33556776 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33542187 |
| 145 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32946331 |
| 146 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32776418 |
| 147 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32078770 |
| 148 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29672449 |
| 149 | Lysosome_Homo sapiens_hsa04142 | 0.29116406 |
| 150 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28784021 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27375191 |
| 152 | Lysine degradation_Homo sapiens_hsa00310 | 0.27094851 |
| 153 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.26995416 |
| 154 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26066310 |
| 155 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.25905663 |
| 156 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25725745 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24106912 |
| 158 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24081887 |
| 159 | Axon guidance_Homo sapiens_hsa04360 | 0.22976089 |
| 160 | Prostate cancer_Homo sapiens_hsa05215 | 0.22742629 |
| 161 | Peroxisome_Homo sapiens_hsa04146 | 0.21559080 |
| 162 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.21172519 |
| 163 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20600966 |
| 164 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.20206130 |
| 165 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19619455 |
| 166 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.19342223 |
| 167 | Focal adhesion_Homo sapiens_hsa04510 | 0.19081072 |
| 168 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18047008 |
| 169 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.17418270 |
| 170 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15940134 |
| 171 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.15903196 |
| 172 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15643924 |

